Research questions liver disease prevalence in IBD

April 7, 2014 by Chris Thomas, Science Network WA
It has always been recognised that up to five per cent of inflammatory bowel disease patients may have significant liver disease. Credit: Peter Gerdes

Do inflammatory bowel disease (IBD) patients have a higher prevalence of clinically significant liver disease?

It's a question researchers from Fremantle Hospital's Centre for Inflammatory Bowel Disease and Department of Gastroenterology, along with Curtin University's Centre for Population Health Research, set out to explore in a study to evaluate the claim.

Researchers used transient elastrography for the study, a way of measuring the elastic modulus – or stiffness – of the liver using sonic detection via an ultrasound-like probe in a machine known as a FibroScan.

The is measured in kilopascals, correlated to fibrosis, and is done without invasive investigation to deliver immediate results.

Lead author Dr Lena Thin says it has always been recognised that up to five per cent of IBD patients may have significant liver disease due to many multifactorial causes such as drugs, fatty liver disease and (PSC).

But this may have been over or underestimated due to a reliance on and abnormal liver tests (where are checked and found to be atypical).

IBD patients with Crohn's disease and ulcerative colitis, the two main forms of IBD, were tested (110 total) against 55 in a control group.

There were no significant differences in liver stiffness between the two groups, although age and increased body mass index did independently cause it to be higher in the IBD group.

"The frequency of occult liver disease in IBD patients is low and this was confirmed using transient elastography in this study," Dr Thin says.

"The main cause of liver disease found was thought to be due to , just as it is in the general population.

"It means we must pay attention to metabolic risk factors in our patients and aim for minimisation of corticosteroid use [steroid hormones]."

Still uncertainty in detection of chloestatic liver diseases

Centre for Inflammatory Bowel Disease director Professor Ian Lawrance, another of the study's authors, says while significant in the IBD patients was found to be no greater than in the general population, this "may not be fully true" with recent data about PSC.

Dr Thin says this stems from the fact the FibroScan has not been shown to be particularly accurate in predicting fibrosis in chloestatic liver diseases.

"The incidence of PSC in IBD may be a lot higher than previously thought," she says.

Explore further: Large-scale genetic study defines relationship between primary sclerosing cholangitis and other autoimmune diseases

More information: "Detection of liver injury in IBD using transient elastography." Thin LW, et al. J Crohns Colitis. 2014 Feb 12. pii: S1873-9946(13)00439-X. DOI: 10.1016/j.crohns.2013.12.006. [Epub ahead of print]

Related Stories

Large-scale genetic study defines relationship between primary sclerosing cholangitis and other autoimmune diseases

April 21, 2013
For the first time, scientists show that a leading cause of liver transplant, primary sclerosing cholangitis (PSC), is a distinct disease from inflammatory bowel disease, opening up new avenues for specific PSC treatments.

Inflammatory bowel disease raises risk of melanoma

May 20, 2013
Patients with inflammatory bowel disease (IBD) are at higher risk of melanoma, a form of skin cancer, report researchers at Mayo Clinic. Researchers found that IBD is associated with a 37 percent greater risk for the disease. ...

Consuming coffee linked to lower risk of detrimental liver disease, study finds

May 19, 2013
Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...

Melanoma risk up in IBD independent of biologic therapy

January 31, 2014
(HealthDay)—Inflammatory bowel disease (IBD) is associated with an increased risk of melanoma, independent of the use of biologic therapy, according to research published in the February issue of Clinical Gastroenterology ...

Fast, painless alternative to liver biopsies for hepatitis patients proves accurate and reliable

October 31, 2013
A non-invasive alternative to liver biopsy, now the standard method of diagnosing cirrhosis in hepatitis patients, proved very reliable in a national multi-center study including Henry Ford Hospital.

Hepatitis C remains major problem for HIV patients despite antiretroviral therapy

March 17, 2014
A new study led by researchers at the Perelman School of Medicine at the University of Pennsylvania has found that the risk of hepatitis C-associated serious liver disease persists in HIV patients otherwise benefitting from ...

Recommended for you

A new theory on reducing cardiovascular disease risk in binge drinkers

January 23, 2018
A new study shows that binge drinkers have increased levels of a biomarker molecule—microRNA-21—that may contribute to poor vascular function.

Flu infection study increases understanding of natural immunity

January 23, 2018
People with higher levels of antibodies against the stem portion of the influenza virus hemagglutinin (HA) protein have less viral shedding when they get the flu, but do not have fewer or less severe signs of illness, according ...

New long-acting approach for malaria therapy developed

January 22, 2018
A new study, published in Nature Communications, conducted by the University of Liverpool and the Johns Hopkins University School of Medicine highlights a new 'long acting' medicine for the prevention of malaria.

Virus shown to be likely cause of mystery polio-like illness

January 22, 2018
A major review by UNSW researchers has identified strong evidence that a virus called Enterovirus D68 is the cause of a mystery polio-like illness that has paralysed children in the US, Canada and Europe.

Creation of synthetic horsepox virus could lead to more effective smallpox vaccine

January 19, 2018
UAlberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox. The discovery demonstrates how techniques based on the use of synthetic DNA can be used to ...

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.